What is the current price and trading status of MDR.AX stock?

MDR.AX is trading at **A$0.022** pre-market on 20 Mar 2026. Day low is **A$0.020**, day high **A$0.022**, and volume is **59,301** shares against an average of **1,383,220**

What short-term price target does the analysis suggest for MDR.AX stock?

The oversold bounce plan targets **A$0.035** as a near-term take-profit and **A$0.050** as a secondary target if volume and fundamentals improve. Use a protective stop at **A$0.019**

How does Meyka AI rate MDR.AX and what does the forecast show?

Meyka AI rates MDR.AX **69.37/100 (Grade B, HOLD)**. The model projects a short-term bounce to **A$0.035** (≈**59.09%** upside from A$0.022). Forecasts are model projections and not guarantees

What are the main risks to the oversold bounce trade for MDR.AX stock?

Main risks include continued negative EPS (**-0.11**), low cash per share (**A$0.017**), thin liquidity, and potential dilution. A lack of volume on any bounce increases failure risk

AU Stocks

MDR.AX MedAdvisor (ASX) A$0.022 pre-market 20 Mar 2026: Oversold bounce targets A$0.035

ByDanny Kontos March 19, 2026

MDR.AX stock trades at A$0.022 in pre-market trade on 20 Mar 2026, a level near the 52-week low A$0.019 that flags a possible oversold bounce. Volume is light at 59,301 shares versus an average of 1,383,220, but short-term technicals and stretched valuation metrics suggest a mean-reversion setup. We outline catalysts, risks, and a trade plan that targets a conservative bounce to A$0.035. This analysis uses company metrics, sector context and Meyka AI tools to frame price action for ASX-listed MedAdvisor Limited